Price Chart

Executive Summary

Macerich is offering 16,000,000 shares of common stock (plus a 30-day underwriter option for 2,400,000 additional shares) in a public offering. The net proceeds will be used to repay borrowings under its revolving credit facility, which were primarily used to fund the recent $260M acquisition of Annapolis Mall. This offering follows a Q1 2026 earnings beat on FFO but a 3.1% YoY revenue decline, and the dilutive share issuance is a material negative signal given the backdrop of declining revenue.

Key Facts

• Macerich is offering 16,000,000 shares of common stock, with an option for underwriters to purchase up to an additional 2,400,000 shares.
• Proceeds will be used to repay borrowings under the revolving credit facility, which funded the $260.0M acquisition of Annapolis Mall and the $12.0M adjacent Sears parcel.
• As of May 8, 2026, Macerich had $250.0M outstanding under its revolving credit facility, bearing interest at SOFR plus 1.90%.
• The offering is underwritten by Goldman Sachs & Co. LLC as book-running manager.
• The filing is a preliminary prospectus supplement (Subject to Completion) with pricing terms (public offering price, underwriting discount, net proceeds) left as placeholders.
• Q1 2026 earnings (filed 5 days prior) showed FFO as adjusted of $0.34 per share (beat consensus of $0.31 by 9.7%), but total revenue declined 3.1% YoY to $241.5M.
• Post-offering, Macerich will have 277,381,187 shares outstanding (279,781,187 if the option is exercised in full), up from 261,381,187 shares as of May 8, 2026.
• The company has been actively issuing shares under its ATM program, selling ~0.9M shares at a weighted average price of $19.99 between March 31 and May 8, 2026, generating ~$18.3M in gross proceeds.

Financial Impact

Dilution of approximately 6.1% (16M new shares / 261.4M existing shares), with potential for up to 7.0% dilution if the underwriter option is exercised. The offering size is ~$350M at the $21.87 reference price, but the actual offering price is undisclosed.

Risk Factors

• Dilution of approximately 6.1% to 7.0% for existing shareholders.
• Revenue declined 3.1% YoY in Q1 2026, indicating underlying operational weakness despite FFO beat.
• The company has been actively issuing shares via ATM, adding to dilution pressure.
• The offering is underwritten by Goldman Sachs, which is also a lender under the revolving credit facility being repaid, creating a potential conflict of interest.
• The preliminary prospectus has placeholder pricing, creating uncertainty about the final terms.

Market Snapshot

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

US Market Status

Related Tickers